Title: THE GLOBAL PLAN TO STOP TB,
1- THE GLOBAL PLAN TO STOP TB,
- 2006-2015
- Marcos Espinal
- Executive Secretary
- Stop TB Partnership
- Joint Meeting of the DOTS Expansion, TB/HIV and
DOTS-Plus Working Groups - 18 October, 2005
- Paris
2Presentation on Global Plan to Stop TB
- Outline of development of Global Plan
- what is the Global Plan?
- why do we need a Global Plan?
- the process of developing the Plan
- regional scenarios and Working Group plans
- expected impact
- next steps
3The Global Plan
- the Stop TB Partnership's plan for TB control
over the decade 2006-2015, in working towards the
goal to eliminate TB as a global public health
problem by 2050 - a convincing argument for the resources needed
for action, underpinned by rigorous
epidemiological analysis with robust budget
justifications
4The Global Plan (contd.)
- What activities are necessary (aimed towards
reaching the Stop TB Partnership's targets for
2015)? - At what cost?
- With what impact (implementation WGs)?
5MDG 6 target 8
- "to have halted by 2015, and begun to reverse the
incidence" of TB
6The Stop TB Partnership's targets
- by 2005
- at least 70 of people with infectious TB will
be diagnosed and at least 85 cured - by 2015
- the global burden of TB disease (prevalence and
deaths) will be reduced by 50 relative to 1990
levels - (reducing prevalence to 155/100,000 and deaths
to 14/100,000 per year by 2015) - by 2050
- the global incidence of TB disease will be less
than 1 case per million population
7Why do we need a Global Plan to Stop TB?
- As a vision of what we can achieveAs a roadmap
to achieve targetsAs a tool for advocacy and
fundraisingTo support long-term national
planningTo stimulate research and development
8Process for developing the Global Plan to Stop TB
- Process is
- coordinated by Stop TB Partnership secretariat
- informed by feedback from first Global Plan
- guided by the Steering Committee
- driven by need to achieve 2015 targets in each
region - dependent on contributions of the 7 Stop TB
Partnership WG -
- (DOTS Expansion, DOTS-Plus, TB/HIV, drugs,
diagnostics, vaccines, and advocacy,
communications social mobilisation) and of the
Secretariat - based for implementation Working Groups on
developing projections of the expected impact and
costs of interventions needed to achieve 2015
targets
9Global Plan has two key dimensions
- Strategic plans of Working Groups and of
Secretariat - Regional scenarios
10Benefits for each WG of development of strategic
plan
- Process
- engages stakeholders
- clarifies activities in line with strategic
direction - aids prioritisation
- identifies resource needs
- Product
- sets out activities (with timelines) linked to
targets - enables monitoring of progress towards goal
- helps resource mobilisation
11Nine epidemiological regions of the world
AFR high HIV
AFR low HIV
Central Europe
Eastern Europe
Established Market Economy
EMR
LAC
SEAR
WPR
12Implementation of DOTS, DOTS-plus and TB-HIV
- DOTS enhanced
- Expand DOTS, improve quality and effectiveness
- Community care, public-private or public-public
mix (PPM), PAL - New labs for culture and drug susceptibility
testing (DST) - DOTS-plus
- DST (new and retreatment)
- Treatment (new) or retreatment (previous) MDR-TB
- TB-HIV
- Active search for TB among HIV-infected, with TB
treatment or isoniazid preventive therapy (IPT) - HIV testing for TB patients, with antiretroviral
therapy (ART) and/or cotrimoxazole (CPT) TB
treatment - Advocacy, communication, social mobilization
13Development of regional scenarios
- Step 1. Defining and costing intervention
packages - e.g. DOTS expansion (complete DOTS coverage,
improved quality of DOTS, PPM DOTS, community
DOTS, PAL, culture services, DST and new
diagnostics). - Step 2. Estimating the magnitude and pace of
scaling up of activities - Step 3. Estimating TB control outcomes and impact
- Step 4. Estimating the cost of DOTS expansion,
DOTS-Plus, TB/HIV and diagnostics
14(No Transcript)
15(No Transcript)
16Summary of planned achievements of R D WGs
17(No Transcript)
18(No Transcript)
19(No Transcript)
20Summary of main messages (1)
- Over the ten years of this Plan, about 50 million
people will be treated for TB under the Global
Strategy to Stop TB, including about 800,000
MDR-TB patients, and about 3 million TB/HIV
patients will be enrolled on ART. - Some 14 million lives will be saved from
2006-2015. - The first new TB drug for 40 years will be
introduced in 2010, with a new short TB regimen
(1-2 months) shortly after. - By 2010 "point of care" diagnostics will enable
rapid, sensitive and inexpensive detection of
active TB. By 2012, a diagnostic toolbox will
accurately identify people with latent TB
infection and those at high risk of progression
to disease.
21Summary of main messages (2)
- Full funding (US 55 billion) for implementation
of the Plan would result in achievement of - the MDG "to have halted by 2015, and begun to
reverse the incidence" of TB - the Partnerships 2015 targets to halve
prevalence and death rates from a 1990 baseline
globally, with enormous progress in all regions - the 2015 targets most likely later than 2015 in
- E Europe and even later in Africa
22Conclusion together let's Stop TB!
- Next steps
- 1. Global Plan launch at the World Economic Forum
at Davos, 29 January 2006 - 2. Use the Global Plan
- a) to mobilise funds
- to continue current levels of funding
- to fill the US 35 billion funding gap
- (depends on the commitment of national
governments and all those who fund TB control,
and on fulfilling this commitment) - b) to inform the development of regional plans to
Stop TB - c) to assess progress in implementation of the WG
and secretariat strategic plans - 3. Measure impact